EARNINGS: Silver Bullet bookings rise; Blackbird hits milestones

AIM WINNERS & LOSERS: React Group swings to loss and lowers outlook

IN BRIEF: Poolbeg Pharma appoints former Amryt executives to team

Poolbeg Pharma makes ‘significant’ influenza breakthrough with AI

Poolbeg Pharma says initial POLB 001 data shows positive response

Poolbeg Pharma AI model of respiratory syncytial virus starts analysis

Poolbeg Pharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.